AVITA Medical, Inc. (RCEL) Intangibles (2019 - 2026)

AVITA Medical (RCEL) has reported Intangibles for 8 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles rose 11.86% year-over-year to $6.5 million; the trailing twelve-month figure through Jun 2026 stood at $6.5 million (up 11.86% YoY), and the FY2025 full-year result was $6.5 million, up 12.25% from the prior year.
• Intangibles steadied at $6.5 million in Q2 2026 per RCEL's latest filing, from $6.5 million in the prior quarter.
• Across five years, Intangibles topped out at $6.5 million in Q2 2026 and bottomed at $558000.0 in Q4 2022.
• Historically, Intangibles has averaged $2.5 million across 5 years, with a median of $700000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Intangibles retreated 20.71% in 2023, then jumped 836.69% in 2024.
• Over 5 years, Intangibles stood at $558000.0 in 2022, then grew by 10.39% to $616000.0 in 2023, then surged by 836.69% to $5.8 million in 2024, then advanced by 12.25% to $6.5 million in 2025, then grew by 0.03% to $6.5 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $6.5 million, $6.5 million, and $5.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.